2008
DOI: 10.1517/14728222.12.10.1243
|View full text |Cite
|
Sign up to set email alerts
|

Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors

Abstract: Background : Topoisomerase I is required for DNA relaxation during critical cellular functions. The identification of camptothecins as specific enzyme inhibitors and their clinical efficacy have stimulated extensive efforts to exploit topoisomerase I as a tumor target and explain the putative mechanisms of antitumor-specific action. Objective : This review provides an overview of the recent achievements in the development of topoisomerase I inhibitors and in the explanation of the biological pathways involved … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
31
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 59 publications
(33 citation statements)
references
References 92 publications
2
31
0
Order By: Relevance
“…These enzymes have been identified as important targets in cancer chemotherapy and microbial infections (Kumar Singh et al 2007). In fact, topoisomerase I inhibitors are quoted as having a wide range of antitumor activities and are among the most widely used anticancer drugs clinically (Sunami et al 2009;Rothenberg 1997;Beretta et al 2008;Teicher 2008;Pommier 2008). However, not many metal complexes have been reported to inhibit topoisomerases.…”
Section: Introductionmentioning
confidence: 99%
“…These enzymes have been identified as important targets in cancer chemotherapy and microbial infections (Kumar Singh et al 2007). In fact, topoisomerase I inhibitors are quoted as having a wide range of antitumor activities and are among the most widely used anticancer drugs clinically (Sunami et al 2009;Rothenberg 1997;Beretta et al 2008;Teicher 2008;Pommier 2008). However, not many metal complexes have been reported to inhibit topoisomerases.…”
Section: Introductionmentioning
confidence: 99%
“…The design of novel analogues is aimed at overcoming the primary limitations of conventional CPTs, including lactone instability, reversibility of drug-target interactions and drug resistance. [25,28] Recent evidence supports to hypothesis that lipophilicity may confer potential advantages to CPTs in terms of cytotoxic potency, likely related to favorable cellular pharmacokinetics, and lactone stability. [29] Among these efforts, we previously reported the potential interest of 16 a-thiocamptothecin.…”
Section: Discussionmentioning
confidence: 82%
“…These topoisomerases are important in DNA replication and transcription. Topo I inhibitors have been reported to be among the most widely used clinical drugs for treatment of cancer [55][56][57][58][59]. Gel electrophoresis can be used to view the topoisomers which result from relaxation of supercoiled pBR322 by Topo I [60].…”
Section: Topo I Inhibitionmentioning
confidence: 99%